Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02980484 · ClinicalTrials.gov registry record · Phase 2
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT02980484 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT02980484, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This pilot study aims to investigate the efficacy of fMRI-targeted repetitive transcranial magnetic stimulation (rTMS) in treatment of major depression associated with traumatic brain injury (TBI). Half of patients will receive active treatment, while the other will receive a sham treatment with the option of receiving open-label active treatment afterwards.
Interventions
- PROCEDURE Sham
- PROCEDURE Active
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02980484
The ClinicalTrials.gov registry entry for NCT02980484 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT02980484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02980484 about?
NCT02980484 is a clinical study titled "fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI". This pilot study aims to investigate the efficacy of fMRI-targeted repetitive transcranial magnetic stimulation (rTMS) in treatment of major depression associated with traumatic brain injury (TBI). Half of patients will receive active treatment, while the other will receive a sham treatment with the...
What is the current status of trial NCT02980484?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2016-08. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02980484?
The interventions under investigation include: Sham (PROCEDURE), Active (PROCEDURE).
Who is sponsoring clinical trial NCT02980484?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.